The Effect of Various Fenoldopam Doses on Renal Perfusion in Patients Undergoing Cardiac Surgery

Annals of Thoracic Surgery

Volumn 89, Issue 2, 2010, Pages 497-503

  Meco, Massimo ^a   Cirri, Silvia ^a  

^a Sant'Ambrogio Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FENOLDOPAM MESILATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; FEMALE; HEART INDEX; HUMAN; KIDNEY BLOOD FLOW; KIDNEY PARENCHYMA; KIDNEY PERFUSION; MALE; PRIORITY JOURNAL;

AGED; BLOOD FLOW VELOCITY; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FENOLDOPAM; FOURIER ANALYSIS; HEMODYNAMICS; HUMANS; KIDNEY; MALE; MIDDLE AGED; RENAL ARTERY; VASODILATOR AGENTS;

EID: 74549189281     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.09.071     Document Type: Article

References (20)

1. Kien N.D., Moore P.G., and Jaffe R.S. Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs. Anesth Analg 74 (1992) 72-78
2. Mathur V.S., Swan S.K., Lambrecht L.J., et al. The effects of fenoldopam, a selective dopamine receptor agonist on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 27 (1999) 1832-1837
3. Cogliati A.A., Vellutini R., Nardini A., et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth 21 (2007) 847-850
4. Nagueh S.F., Middeton K.S., Kopelen H.A., et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30 (1997) 1527-1533
5. Garwood S., Davis E., and Harris S.N. Intraoperative transoesophageal ultrasonography can measure renal blood flow. J Cardiothorac Vasc Anesth 15 (2001) 65-71
6. Yura T., Yuasa S., Fukunaga M., et al. Role for Doppler ultrasound in the assessment of renal circulation: effects of dopamine and dobutamine on renal hemodynamics in humans. Nephron 71 (1995) 168-175
7. Loriga G., Vidili G., Ruggenti P., et al. Renal hemodynamics and renoprotection. Nephron Clin Pract 110 (2008) 213-219
8. Aravindan N., Samuels J., Riedel B., et al. Fenoldopam improves corticomedullary oxygen delivery and attenuates angiogenesis gene expression in acute ischemic renal injury. Kidney Blood Press Res 29 (2006) 165-174
9. Yasir A.O., and Chandana R. Cardiopulmonary bypass and renal injury. Perfusion 21 (2006) 209-213
10. Brezis M., and Rosen S. Hypoxia of the renal medulla. Its implications for disease. N Engl J Med 332 (1995) 647-655
11. Manson J., Torhorst J., and Welsch J. Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int 26 (1984) 283-293
12. Stone G.W., McCullough P.A., Tumlin J., et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290 (2003) 2284-2291
13. Bakris G.L., Lass N.A., and Glock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int 56 (1999) 206-210
14. Madyoon H., Croushore L., Weaver D., et al. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients. Catheter Cardiovasc Interv 53 (2001) 341-345
15. Asif A., Epstein D.L., and Epstei M. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy. J Clin Pharmacol 44 (2004) 1342-1351
16. Bove T., Landoni G., Calabrò M.G., et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery. A prospective, double blind, randomized clinical trial. Circulation 111 (2005) 3230-3235
17. Ranucci M., Soro G., Barzaghi N., et al. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 78 (2004) 1332-1337
18. Roasio A., Lobreglio R., Santin A., et al. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. J Cardiothorac Vasc Anesth 22 (2008) 23-26
19. Caimmi P.P., Pagani L., Micalizzi E., et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17 (2003) 491-494
20. Landoni G., Biondi-Zoccai G.G., Tumlin J.A., et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 49 (2007) 56-68